Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...

Veracyte (VCYT) delivered earnings and revenue surprises of 55% and 3.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

On March 7, 2025, Veracyte, Inc. (NASDAQ:VCYT) stock closed at $32.02 per share with a market capitalization of $2.496 billion.

Investors in Veracyte Inc (Symbol: VCYT) saw new options begin trading this week, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VCYT ...

Veracyte VCYT has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 composite’s 24.4% gain ...

Veracyte (VCYT – Research Report) received a Hold rating and price target from Goldman Sachs analyst Matthew Sykes today. The company’s shares opened today at $42.00.

Veracyte Price Performance Shares of NASDAQ:VCYT opened at $31.32 on Tuesday. Veracyte has a 1-year low of $19.73 and a 1-year high of $47.32. The stock has a market cap of $2.45 billion, a P/E ...

Veracyte, Inc. (NASDAQ: VCYT) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Shayla Gorman - Senior Director, Investor Relations Marc Stapley - Chief Executive ...

Veracyte, Inc. (NASDAQ:VCYT) generated revenue of $114.5 million in the first quarter of fiscal 2025, marking a 18% increase from last year’s comparable quarter.

Veracyte (NASDAQ:VCYT – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Friday.

Ace hedge fund manager Cathie Wood made some interesting trades on July 25, according to ARK Invest’s daily trade updates. Wood sold $16.46 ...